中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(7): 1584-1589

Clinical features of Klebsiella pneumoniae liver abscess and influencing factors for prognosis

DOI: 10.3969/j.issn.1001-5256.2022.07.023

  • Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China

Research funding:

Beijing Municipal Science and Technology Commission (D171100003117005);

Digestive Medical Coordinated Development Center of Beijing Municipal Administration (XXZ0402);

Beijing Hospitals Authority of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201808)

More Information
  • Corresponding author: XIE Wen, xiewen6218@163.com(ORCID: 0000-0002-7314-8175)
  • Received Date: 2021-11-29
  • Accepted Date: 2022-03-08
  • Published Date: 2022-07-20
    Abstract
  •   Objective  To investigate the clinical features of Klebsiella pneumoniae liver abscess and the influencing factors for prognosis.  Methods  A retrospective analysis was performed for the patients with liver abscess who were hospitalized and had positive blood culture or pus culture in Beijing Ditan Hospital, Capital Medical University, from January 2010 to January 2020, and according to the results of etiology, these patients were divided into Klebsiella pneumoniae group (KP group) and non-Klebsiella pneumoniae group (non-KP group). Clinical features were compared between the two groups. The two-independent-samples t test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. A multivariate logistic regression analysis was used to identify independent influencing factors for poor prognosis, and a nomogram predictive model was established based on these factors. Index of concordance (C-index) was used for internal validation, and a decision curve analysis was also performed.  Results  A total of 89 patients with liver abscess were enrolled, with 48 patients in the KP group and 41 in the non-KP group. Compared with the non-KP group, the KP group had a significantly higher proportion of patients with type 2 diabetes mellitus (χ2=12.508, P < 0.001), hypertension (χ2=4.215, P=0.04), or fatty liver disease (χ2=6.832, P=0.009) and a significantly lower proportion of patients with a medical history of malignant tumor (χ2=15.039, P < 0.001), human immunodeficiency virus infection (χ2=15.039, P < 0.001), or a medical history of gallstones (χ2=5.834, P=0.016), as well as a significantly lower proportion of patients with the outcome of death (χ2=4.115, P=0.042). Compared with the non-KP group, the KP group had significantly higher levels of leukocyte count (Z=-2.087, P=0.037), hemoglobin (t=4.67, P < 0.001), fibrinogen (Z=-3.300, P=0.001), C-reactive protein (Z=-3.276, P=0.001), procalcitonin (Z=-0.361, P < 0.001), and alanine aminotransferase (Z=-2.436, P=0.015). The multivariate logistic regression analysis showed that sepsis (odds ratio [OR]=9.110, 95% confidence interval [CI]: 1.268-65.443, P=0.028), pulmonary infection (OR=17.720, 95%CI: 2.661-118.010, P=0.003), and low albumin level (OR=0.815, 95%CI: 0.692-0.960, P=0.016) were the risk factors for poor prognosis of liver abscess, while ultrasound-guided abscess puncture therapy (OR=8.551, 95%CI: 1.549-47.195, P=0.014) was a protective factor for relatively good prognosis of liver abscess.  Conclusion  KP liver abscess may be more likely to occur in patients with diabetes mellitus, hypertension, and fatty liver disease. Sepsis, pulmonary infection, and low albumin level are the risk factors for poor prognosis of liver abscess, while ultrasound-guided abscess puncture is a protective factor for relatively good prognosis. Intervention treatment based on the nomogram predictive model established in this study can effectively improve the prognosis of patients with liver abscess.

     

    • FullText(HTML)
  • loading
    • References(29)
  • [1]
    MOHSEN AH, GREEN ST, READ RC, et al. Liver abscess in adults: ten years experience in a UK centre[J]. QJM, 2002, 95(12): 797-802. DOI: 10.1093/qjmed/95.12.797.
    [2]
    CHEN YC, LIN CH, CHANG SN, et al. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000-2011[J]. J Microbiol Immunol Infect, 2016, 49(5): 646-653. DOI: 10.1016/j.jmii.2014.08.028.
    [3]
    TSAI FC, HUANG YT, CHANG LY, et al. Pyogenic liver abscess as endemic disease, Taiwan[J]. Emerg Infect Dis, 2008, 14(10): 1592-1600. DOI: 10.3201/eid1410.071254.
    [4]
    LIU Y, WANG JY, JIANG W. An increasing prominent disease of Klebsiella pneumoniae liver abscess: Etiology, diagnosis, and treatment[J]. Gastroenterol Res Pract, 2013, 2013: 258514. DOI: 10.1155/2013/258514.
    [5]
    YIN D, JI C, ZHANG S, et al. Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective study[J]. Liver Int, 2021, 41(4): 810-818. DOI: 10.1111/liv.14760.
    [6]
    SIU LK, YEH KM, LIN JC, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome[J]. Lancet Infect Dis, 2012, 12(11): 881-887. DOI: 10.1016/S1473-3099(12)70205-0.
    [7]
    CERWENKA H. Pyogenic liver abscess: differences in etiology and treatment in Southeast Asia and Central Europe[J]. World J Gastroenterol, 2010, 16(20): 2458-2462. DOI: 10.3748/wjg.v16.i20.2458.
    [8]
    RUIZ-HERNÁNDEZ JJ, LEÓN-MAZORRA M, CONDE-MARTEL A, et al. Pyogenic liver abscesses: mortality-related factors[J]. Eur J Gastroenterol Hepatol, 2007, 19(10): 853-858. DOI: 10.1097/MEG.0b013e3282eeb53b.
    [9]
    YANG CC, YEN CH, HO MW, et al. Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae[J]. J Microbiol Immunol Infect, 2004, 37(3): 176-184.
    [10]
    CHUNG DR, LEE SS, LEE HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea[J]. J Infect, 2007, 54(6): 578-583. DOI: 10.1016/j.jinf.2006.11.008.
    [11]
    HUI P, ZHU P, LIAO W, et al. Bacterial flora distribution and antimicrobial resistance of pyogenic liver abscess: a multicenter retrospective study (A report of 897 cases)[J]. Chin J Dig Surg, 2019, 18(10): 924-933. DOI: 10.3760/cma.j.issn.1673-9752.2019.10.007.

    惠鹏, 朱鹏, 廖威, 等. 细菌性肝脓肿菌群分布与耐药性分析的多中心回顾性研究(附897例报告)[J]. 中华消化外科杂志, 2019, 18(10): 924-933. DOI: 10.3760/cma.j.issn.1673-9752.2019.10.007.
    [12]
    LEE JH, JANG YR, AHN SJ, et al. A retrospective study of pyogenic liver abscess caused primarily by Klebsiella pneumoniae vs. non-Klebsiella pneumoniae: CT and clinical differentiation[J]. Abdom Radiol (NY), 2020, 45(9): 2669-2679. DOI: 10.1007/s00261-019-02389-2.
    [13]
    XU SB, YANG SY, WENG SS, et al. Clinical characteristics of patients with Klebsiella pneumoniae pyogenic liver abscess[J]. Chin J Intern Med, 2020, 59(6): 439-444. DOI: 10.3760/cma.j.cn112138-20190610-00403.

    徐水宝, 杨思宇, 翁珊珊, 等. 肺炎克雷伯菌肝脓肿临床特征分析[J]. 中华内科杂志, 2020, 59(6): 439-444. DOI: 10.3760/cma.j.cn112138-20190610-00403.
    [14]
    PASTAGIA M, ARUMUGAM V. Klebsiella pneumoniae liver abscesses in a public hospital in Queens, New York[J]. Travel Med Infect Dis, 2008, 6(4): 228-233. DOI: 10.1016/j.tmaid.2008.02.005.
    [15]
    MOORE LS, CLARKE IL, DONALDSON H, et al. Community-acquired Klebsiella pneumoniae liver abscess: the London experience[J]. Infection, 2014, 42(1): 219-221. DOI: 10.1007/s15010-013-0520-1.
    [16]
    FANG CT, LAI SY, YI WC, et al. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess[J]. Clin Infect Dis, 2007, 45(3): 284-293. DOI: 10.1086/519262.
    [17]
    YAO N, KANG W, LIAN JQ, et al. Clinical features of Klebsiella pneumoniae liver abscess versus Escherichia coli liver abscess[J]. J Clin Hepatol, 2020, 36(9): 2010-2014. DOI: 10.3969/j.issn.1001-5256.2020.09.020.

    姚娜, 康文, 连建奇, 等. 肺炎克雷伯菌肝脓肿与大肠埃希菌肝脓肿临床特点对比分析[J]. 临床肝胆病杂志, 2020, 36(9): 2010-2014. DOI: 10.3969/j.issn.1001-5256.2020.09.020.
    [18]
    LIN JC, SIU LK, FUNG CP, et al. Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control[J]. J Clin Endocrinol Metab, 2006, 91(8): 3084-3087. DOI: 10.1210/jc.2005-2749.
    [19]
    CHEN SC, WU WY, YEH CH, et al. Comparison of Escherichia coli and Klebsiella pneumoniae liver abscesses[J]. Am J Med Sci, 2007, 334(2): 97-105. DOI: 10.1097/MAJ.0b013e31812f59c7.
    [20]
    QIAN Y, WONG CC, LAI S, et al. A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015[J]. Sci Rep, 2016, 6: 38587. DOI: 10.1038/srep38587.
    [21]
    YOON JH, KIM YJ, JUN YH, et al. Liver abscess due to Klebsiella pneumoniae: risk factors for metastatic infection[J]. Scand J Infect Dis, 2014, 46(1): 21-26. DOI: 10.3109/00365548.2013.851414.
    [22]
    CAI MT, FAN CL, LI L, et al. Case-control analysis of liver abscess in patients with acquired immunodeficiency syndrome[J]. Chin J Infect Chemother, 2019, 19(5): 465-472. DOI: 10.16718/j.1009-7708.2019.05.001.

    蔡妙甜, 范春蕾, 李磊, 等. 艾滋病肝脓肿患者临床特征的对照分析[J]. 中国感染与化疗杂志, 2019, 19(5): 465-472. DOI: 10.16718/j.1009-7708.2019.05.001.
    [23]
    ASTON SJ. Pneumonia in the developing world: Characteristic features and approach to management[J]. Respirology, 2017, 22(7): 1276-1287. DOI: 10.1111/resp.13112.
    [24]
    NEILL L, EDWARDS F, COLLIN SM, et al. Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess[J]. BMC Infect Dis, 2019, 19(1): 490. DOI: 10.1186/s12879-019-4127-8.
    [25]
    LI S, YU S, PENG M, et al. Clinical features and development of Sepsis in Klebsiella pneumoniae infected liver abscess patients: a retrospective analysis of 135 cases[J]. BMC Infect Dis, 2021, 21(1): 597. DOI: 10.1186/s12879-021-06325-y.
    [26]
    CHENG Y, BAI YF, QIU YP, et al. Clinical features of Klebsiella pneumoniae liver abscess and molecular characteristics of bacterial infection[J]. China Mod Doct, 2021, 59(17): 124-128. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202117030.htm

    程颖, 白永凤, 邱玉萍, 等. 肺炎克雷伯菌肝脓肿的临床特点及感染菌的分子特征[J]. 中国现代医生, 2021, 59(17): 124-128. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS202117030.htm
    [27]
    MATSUKUMA Y, TANAKA S, TANIGUCHI M, et al. Association of geriatric nutritional risk index with infection-related mortality in patients undergoing hemodialysis: The Q-Cohort Study[J]. Clin Nutr, 2019, 38(1): 279-287. DOI: 10.1016/j.clnu.2018.01.019.
    [28]
    SOLOMKIN JS, MAZUSKI JE, BRADLEY JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America[J]. Clin Infect Dis, 2010, 50(2): 133-164. DOI: 10.1086/649554.
    [29]
    LIU L, CHEN W, LU X, et al. Pyogenic liver abscess: A retrospective study of 105 cases in an emergency department from east China[J]. J Emerg Med, 2017, 52(4): 409-416. DOI: 10.1016/j.jemermed.2016.09.026.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (734) PDF downloads(87) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return